Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer

NCT04262869 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Due to accrual issues

Conditions

Lung Non-Small Cell Carcinoma
Stage IIIB Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Stage IVB Lung Cancer AJCC v8

Interventions

DRUG: Carboplatin
BIOLOGICAL: Durvalumab
DRUG: Paclitaxel
DRUG: Pemetrexed

Sponsor

Emory University

Collaborators

[object Object]